Atrandi Biosciences is breaking new ground in high-throughput analysis technologies. Providing simple-to-adopt and easy-to-use droplet microfluidics and high-throughput screening (HTS) workflows. Droplet microfluidics technology is at the core of our products and provides an unmatched platform for exploring the complexity of biology in a high-throughput manner. Droplet microfluidics enables compartmentalizing molecular biology reactions into millions of pico-liter droplets, empowering you to study biological samples at the resolution of single cells and single molecules. Our work is at the intersection of life sciences, engineering, and machine learning. We deliver elegant solutions and novel tools for groundbreaking high-throughput research by integrating different technologies.
Location: Lithuania, Vilnius County, Vilnius
Employees: 11-50
Total raised: $4.895369M
Founded date: 2016
Investors 2
| Date | Name | Website |
| 20.04.2023 | Vsquared V... | vsquared.v... |
| 06.11.2023 | Metaplanet... | metaplanet... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 29.03.2023 | Series A | $4.895369M | Vsquared V... | finsmes.co... |
Mentions in press and media 3
| Date | Title | Description | Source |
| 29.03.2023 | Lithuanian biotech Atrandi Biosciences raises €4.5M in Serie... | Lithuanian biotech Atrandi Biosciences raises €4.5M in Series A funding 29 March, 2023, 12:37 Rost... | ain.capita... |
| 28.03.2023 | Atrandi Biosciences Secures $4.8M in Funding | Atrandi Biosciences, a Vilnius, Lithuania and Denver, CO-based provider of microfluidic solutions fo... | finsmes.co... |
| - | Atrandi Biosciences | “Atrandi Biosciences” | fastfounde... |